TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
GLAS

Glass House Brands Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

6.80$ -0.9% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GLAS
Line item 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0%
75.6% 49.7% 51.5% 57.7%
24.4% 50.3% 48.5% 42.3%
69.5% 39.2% 35.0% 41.7%
159.6% 98.0% 94.0% 108.0%
-59.6% 2.0% 6.0% -8.0%
9.0% 6.1% 4.6% 3.9%
-44.0% -54.8% 5.6% -9.4%
-38.8% -61.1% 0.3% -16.3%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?